Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Balázs Gereben2,
Ann Marie Zavacki2,
Scott Ribich2,
Brian W. Kim,
Stephen A. Huang,
Warner S. Simonides,
Anikó Zeöld and
Antonio C. Bianco
Laboratory of Endocrine Neurobiology (B.G., A.Z.), Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, H-1083 Hungary; Thyroid Section (A.M.Z., S.R., B.W.K., A.C.B.), Division of Endocrinology, Diabetes and Hypertension, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts 02115; Laboratory for Physiology (W.S.S.), Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands; Division of Endocrinology and Metabolism (S.A.H.), Childrens Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115; and Division of Endocrinology (A.C.B.), Diabetes and Metabolism, University of Miami, Miller School of Medicine, Miami, Florida 33136
Correspondence: Address all correspondence and requests for reprints to: Antonio C. Bianco, M.D., Ph.D., Division of Endocrinology, Diabetes and Metabolism, Suite 816, Dominion Towers, 1400 NW 10th Avenue, Miami, Florida 33136. E-mail: abianco{at}deiodinase.org
The iodothyronine deiodinases initiate or terminate thyroidhormone action and therefore are critical for the biologicaleffects mediated by thyroid hormone. Over the years, researchhas focused on their role in preserving serum levels of thebiologically active molecule T3 during iodine deficiency. Morerecently, a fascinating new role of these enzymes has been unveiled.The activating deiodinase (D2) and the inactivating deiodinase(D3) can locally increase or decrease thyroid hormone signalingin a tissue- and temporal-specific fashion, independent of changesin thyroid hormone serum concentrations. This mechanism is particularlyrelevant because deiodinase expression can be modulated by awide variety of endogenous signaling molecules such as sonichedgehog, nuclear factor-B, growth factors, bile acids, hypoxia-induciblefactor-1, as well as a growing number of xenobiotic substances.In light of these findings, it seems clear that deiodinasesplay a much broader role than once thought, with great ramificationsfor the control of thyroid hormone signaling during vertebratedevelopment and metamorphosis, as well as injury response, tissuerepair, hypothalamic function, and energy homeostasis in adults.
This article has been cited by other articles:
L. Calza, M. Fernandez, and L. Giardino Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells
J. Mol. Endocrinol.,
January 1, 2010;
44(1):
13 - 23.
[Abstract][Full Text][PDF]
M. O. Ribeiro, S. D. C. Bianco, M. Kaneshige, J. J. Schultz, S.-y. Cheng, A. C. Bianco, and G. A. Brent Expression of Uncoupling Protein 1 in Mouse Brown Adipose Tissue Is Thyroid Hormone Receptor-{beta} Isoform Specific and Required for Adaptive Thermogenesis
Endocrinology,
January 1, 2010;
151(1):
432 - 440.
[Abstract][Full Text][PDF]
G. Aerts, R. Arrojo e Drigo, S. L. J. Van Herck, E. Sammels, D. Mirebeau-Prunier, B. Gereben, A. Zeold, J. W. Harney, S. A. Huang, M. A. Mulcahey, et al. Knockdown of the Type 3 Iodothyronine Deiodinase (D3) Interacting Protein Peroxiredoxin 3 Decreases D3-Mediated Deiodination in Intact Cells
Endocrinology,
November 1, 2009;
150(11):
5171 - 5180.
[Abstract][Full Text][PDF]
C. Di Cosmo, N. McLellan, X.-H. Liao, K. K. Khanna, R. E. Weiss, L. Papp, and S. Refetoff Clinical and Molecular Characterization of a Novel Selenocysteine Insertion Sequence-Binding Protein 2 (SBP2) Gene Mutation (R128X)
J. Clin. Endocrinol. Metab.,
October 1, 2009;
94(10):
4003 - 4009.
[Abstract][Full Text][PDF]
W. E. Visser, K. A. Heemstra, S. M. A. Swagemakers, Z. Ozgur, E. P. Corssmit, J. Burggraaf, W. F. J. van Ijcken, P. J. van der Spek, J. W. A. Smit, and T. J. Visser Physiological Thyroid Hormone Levels Regulate Numerous Skeletal Muscle Transcripts
J. Clin. Endocrinol. Metab.,
September 1, 2009;
94(9):
3487 - 3496.
[Abstract][Full Text][PDF]
R. N. Margolis, D. D. Moore, T. M. Willson, and R. K. Guy Chemical Approaches to Nuclear Receptors in Metabolism
Sci. Signal.,
August 4, 2009;
2(82):
mr5 - mr5.
[Abstract][Full Text][PDF]
P. R. Larsen Type 2 Iodothyronine Deiodinase in Human Skeletal Muscle: New Insights into Its Physiological Role and Regulation
J. Clin. Endocrinol. Metab.,
June 1, 2009;
94(6):
1893 - 1895.
[Full Text][PDF]
J. A. Hall and A. C. Bianco Triumphs of the Thyroid Despite Lesser Conversion
Endocrinology,
June 1, 2009;
150(6):
2502 - 2504.
[Full Text][PDF]
B. W. Kim and A. C. Bianco For Some, L-Thyroxine Replacement Might Not Be Enough: A Genetic Rationale
J. Clin. Endocrinol. Metab.,
May 1, 2009;
94(5):
1521 - 1523.
[Full Text][PDF]
H. Heuer and T. J. Visser Pathophysiological Importance of Thyroid Hormone Transporters
Endocrinology,
March 1, 2009;
150(3):
1078 - 1083.
[Abstract][Full Text][PDF]